Novel IgG3 antibodies for stimulating phagocytosis

Details for Australian Patent Application No. 2004281220 (hide)

International Classifications

Event Publications

11 May 2006 PCT application entered the National Phase

PCT publication WO2005/037866 Priority application(s): WO2005/037866

10 August 2006 Amendment Made

The nature of the amendment is: Amend the invention title to read IGG3 anti rhesus-D in the line YB2/0 having a high phagocytosis activity

15 January 2009 Assignment before Grant

Laboratoire Francais du Fractionnement et des Biotechnologies The application has been assigned to LFB Biotechnologies

15 April 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.